Acute and Recurrent Vesicular Hand Dermatitis

  • Jacob P. ThyssenEmail author
  • Torkil Menné
Reference work entry


Acute and recurrent vesicular hand dermatitis is a subtype of hand eczema.

This term covers dyshidrotic hand dermatitis (eczema) and pompholyx, terms that should be abandoned.

The disease is characterized by eruptive, vesicular dermatitis reactions that affect the palms, the palmar and lateral aspects of the fingers, and the periungual area.

The vesicles or bullous lesions can be large and deep-seated.

Causes and aggravating factors include emotional stress, hyperhidrosis, weather changes, atopy, mycosis, irritants, contact allergens, and systemic exposure to metals, drugs, and food. However, the cause is often unknown.

Treatment includes primarily removal of causative exposures as well as topical corticosteroids, phototherapy, and in some cases systemic treatment.


Acute Atopic Hand eczema Reccurent Treatment Vesicular 


  1. Agner T, Aalto-Korte K, Andersen KE et al (2015) European environmental and contact dermatitis research group. J Eur Acad Dermatol Venereol Dec 29(12):2417–2422CrossRefGoogle Scholar
  2. Agrup G (1969) Hand eczema and other hand dermatosis in South Sweden. Acta Derm Venereol 49:1–91Google Scholar
  3. Behrens S, von Kobyletzki G, Gruss C, Reuther T, Altmeyer P, Kerscher M (1999) PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed 15:47–51PubMedCrossRefPubMedCentralGoogle Scholar
  4. Belsito DV, Fowler JF Jr, Marks JG Jr, Pariser DM, Hanifin J, Duarte IA, Pires MC, Cruz PD Jr, Langley RG, Patel P, Bush C, Thurston M, Graeber M, Cherill R (2004) Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 73:31–38PubMedPubMedCentralGoogle Scholar
  5. Benedek T (1974) Pompholyx of the hands and feet. Its etiology, pathogenesis and specific vaccine therapy. (formerly: ‘epidermophytosis’ of hands and feet). Mycopathol Mycol Appl 53:25–44PubMedCrossRefPubMedCentralGoogle Scholar
  6. Bollag W, Ott F (1999) Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid. Dermatology 199:308–312PubMedCrossRefGoogle Scholar
  7. Boonstra MB, Christoffers WA, Coenraads PJ, Schuttelaar ML (2015) Patch test results of hand eczema patients: relation to clinical types. J Eur Acad Dermatol Venereol 29(5):940–947. Epub 2014 Sep 15CrossRefPubMedPubMedCentralGoogle Scholar
  8. Brans R, John SM (2016) Clinical patterns and associated factors in patients with hand eczema of primarily occupational origin. J Eur Acad Dermatol Venereol 30(5):798–805. Epub 2015 Dec 9CrossRefPubMedPubMedCentralGoogle Scholar
  9. Brans R, Hübner A, Gediga G, John SM (2015) Prevalence of foot eczema and associated occupational and non-occupational factors in patients with hand eczema. Contact Dermatitis 73(2):100–107. Epub 2015 Feb 25CrossRefPubMedPubMedCentralGoogle Scholar
  10. Bryld LE, Agner T, Kyvik KO, Brondsted L, Hindsberger C, Menné T (2000) Hand eczema in twins: a questionnaire investigation. Br J Dermatol 142:298–305PubMedCrossRefPubMedCentralGoogle Scholar
  11. Bryld LE, Agner T, Menné T (2003) Relation between vesicular eruptions on the hands and tinea pedis, atopic dermatitis and nickel allergy. Acta Derm Venereol 83:186–188PubMedCrossRefPubMedCentralGoogle Scholar
  12. Castelain PY (1987) Dysidrosis. Ann Dermatol Venereol 114:579–585PubMedPubMedCentralGoogle Scholar
  13. Chen JJ, Liang YH, Zhou FS, Yang S, Wang J, Wang PG, WH D, SJ X, Huang W, Zhang XJ (2006) The gene for a rare autosomal dominant form of pompholyx maps to chromosome 18q22.1-18q22.3. J Invest Dermatol 126:300–304PubMedCrossRefPubMedCentralGoogle Scholar
  14. Christensen OB, Lindstrom C, Löfberg H, Möller H (1981) Micromorphology and specificity of orally induced flare-up reactions in nickel-sensitive patients. Acta Derm Venereol 61:505–510PubMedPubMedCentralGoogle Scholar
  15. Christoffers WA, Politiek K, Coenraads PJ et al (2016) Drug survival of cyclosporine in the treatment of hand eczema: a multicentre, daily use study. J Eur Acad Dermatol Venereol 30(1):63–66. Scholar
  16. Cox JS (1971) Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug. Br J Dis Chest 65:189–204PubMedCrossRefPubMedCentralGoogle Scholar
  17. Crosti C, Lodi A (1993) Pompholyx: a still unresolved kind of eczema. Dermatology 186:241–242PubMedCrossRefPubMedCentralGoogle Scholar
  18. Davis MD, McEvoy MT, el-Azhary RA (1998) Topical psoralen-ultraviolet a therapy for palmoplantar dermatoses: experience with 35 consecutive patients. Mayo Clin Proc 73:407–411PubMedCrossRefPubMedCentralGoogle Scholar
  19. de Boer EM, Bruynzeel DP, van Ketel WG (1988) Dyshidrotic eczema as an occupational dermatitis in metal workers. Contact Dermatitis 19:184–188PubMedCrossRefPubMedCentralGoogle Scholar
  20. Diepgen TL, Andersen KE, Brandao FM, Bruze M, Bruynzeel DP, Frosch P, Goncalo M, Goossens A, Le Coz CJ, Rustemeyer T, White IR, Agner T (2009) Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol 160:353–358PubMedCrossRefGoogle Scholar
  21. Diepgen TL, Pfarr E, Zimmermann T (2012) Efficacy and tolerability of alitretinoin for chronic hand eczema under daily practice conditions: results of the TOCCATA open study comprising 680 patients. Acta Derm Venereol 92(3):251–255PubMedCrossRefGoogle Scholar
  22. Douwes KE, Karrer S, Abels C, Landthaler M, Szeimies RM (2000) Does smoking influence the efficacy of bath-PUVA therapy in chronic palmoplantar eczema? Photodermatol Photoimmunol Photomed 16:25–29PubMedCrossRefPubMedCentralGoogle Scholar
  23. Edman B (1988) Palmar eczema: a pathogenetic role for acetylsalicylic acid, contraceptives and smoking? Acta Derm Venereol 68:402–407PubMedPubMedCentralGoogle Scholar
  24. Egan CA, Rallis TM, Meadows KP, Krueger GG (1999) Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 40:612–614PubMedCrossRefPubMedCentralGoogle Scholar
  25. Ekelund AG, Möller H (1969) Oral provocation in eczematous contact allergy to neomycin and hydroxy-quinolines. Acta Derm Venereol 49:422–426PubMedPubMedCentralGoogle Scholar
  26. Fairris GM, Jones DH, Mack DP, Rowell NR (1985) Conventional superficial X-ray versus Grenz ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol 112:339–341PubMedCrossRefPubMedCentralGoogle Scholar
  27. Fairris GM, Mack DP, Rowell NR (1984) Superficial X-ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol 111:445–449PubMedCrossRefPubMedCentralGoogle Scholar
  28. Flood JM, Perry DJ (1946) Recurrent vesicular eruption of the hands due to food allergy. J Invest Dermatol 7:309–327PubMedCrossRefPubMedCentralGoogle Scholar
  29. Fowler JF, Graff O, Hamedani AG (2014) A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy. J Drugs Dermatol 13(10):1198–1204PubMedPubMedCentralGoogle Scholar
  30. Granlund H, Erkko P, Eriksson E, Reitamo S (1996) Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 76:371–376PubMedGoogle Scholar
  31. Grattan CE, Carmichael AJ, Shuttleworth GJ, Foulds IS (1991) Comparison of topical PUVA with UVA for chronic vesicular hand eczema. Acta Derm Venereol 71:118–122PubMedPubMedCentralGoogle Scholar
  32. Guillet MH, Wierzbicka E, Guillet S, Dagregorio G, Guillet G (2007) A 3-year causative study of pompholyx in 120 patients. Arch Dermatol 143:1504–1508PubMedCrossRefPubMedCentralGoogle Scholar
  33. Hansen O, Kuchler T, Lotz GR, Richter R, Wilckens A (1981) My fingers itch, but my hands are bound. An exploratory psychosomatic study of patients with dyshidrosis of the hands (cheiropompholyx). Z Psychosom Med Psychoanal 27:275–290PubMedPubMedCentralGoogle Scholar
  34. Iannaccone S, Sferrazza B, Quattrini A, Smirne S, Ferini-Strambi L (1999) Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease. Neurology 53:1154–1155PubMedCrossRefPubMedCentralGoogle Scholar
  35. Jain VK, Aggarwal K, Passi S, Gupta S (2004) Role of contact allergens in pompholyx. J Dermatol 31:188–193PubMedCrossRefPubMedCentralGoogle Scholar
  36. Jensen CS, Menné T, Johansen JD (2006) Systemic contact dermatitis after oral exposure to nickel: a review with a modified meta-analysis. Contact Dermatitis 54:79–86PubMedCrossRefPubMedCentralGoogle Scholar
  37. Jensen CS, Menné T, Lisby S, Kristiansen J, Veien NK (2003) Experimental systemic contact dermatitis from nickel: a dose-response study. Contact Dermatitis 49:124–132PubMedCrossRefPubMedCentralGoogle Scholar
  38. Kaaber K, Menné T, Veien N, Hougaard P (1983) Treatment of nickel dermatitis with Antabuse; a double blind study. Contact Dermatitis 9:297–299PubMedCrossRefPubMedCentralGoogle Scholar
  39. Kaaber K, Veien NK, Tjell JC (1978) Low nickel diet in the treatment of patients with chronic nickel dermatitis. Br J Dermatol 98:197–201PubMedCrossRefPubMedCentralGoogle Scholar
  40. Kellum RE (1973) Dyshidrotic hand eczema: a psychotherapeutic approach. Cutis 16:875–878Google Scholar
  41. King CM, Chalmers RJ (1984) A double-blind study of superficial radiotherapy in chronic palmar eczema. Br J Dermatol 111:451–454PubMedCrossRefPubMedCentralGoogle Scholar
  42. Kodlys KW, Meyer RP (1979) Biofeedback training in the therapy of dyshidrosis. Cutis 24:219–221Google Scholar
  43. Kutzner H, Wurzel RM, Wolff HH (1986) Are acrosyringia involved in the pathogenesis of “dyshidrosis”? Am J Dermatopathol 8:109–116PubMedCrossRefPubMedCentralGoogle Scholar
  44. Lantinga H, Nater JP, Coenraads PJ (1984) Prevalence, incidence and course of eczema on the hands and forearms in a sample of the general population. Contact Dermatitis 10:135–139PubMedCrossRefGoogle Scholar
  45. Lee WJ, Lee DW, Kim CH, Won CH, Chang SE, Lee MW, Choi JH, Moon KC (2009) Pompholyx with bile-coloured vesicles in a patient with jaundice: are sweat ducts involved in the development of pompholyx? J Eur Acad Dermatol Venereol 24(2):235–236PubMedCrossRefPubMedCentralGoogle Scholar
  46. Lehucher-Michel MP, Koeppel MC, Lanteaume A, Sayag J (2000) Dyshidrotic eczema and occupation: a descriptive study. Contact Dermatitis 43:200–205PubMedCrossRefPubMedCentralGoogle Scholar
  47. Lerbaek A, Kyvik KO, Ravn H, Menné T, Agner T (2007) Incidence of hand eczema in a population-based twin cohort: genetic and environmental risk factors. Br J Dermatol 157:552–557PubMedCrossRefPubMedCentralGoogle Scholar
  48. Lerbaek A, Kyvik KO, Ravn H, Menné T, Agner T (2008) Clinical characteristics and consequences of hand eczema – an 8-year follow-up study of a population-based twin cohort. Contact Dermatitis 58:210–216PubMedCrossRefGoogle Scholar
  49. LeVine MJ, Parrish JA, Fitzpatrick TB (1981) Oral methoxsalen photochemotherapy (PUVA) of dyshidrotic eczema. Acta Derm Venereol 61:570–571PubMedPubMedCentralGoogle Scholar
  50. Lodi A, Betti R, Chiarelli G, Urbani CE, Crosti C (1992) Epidemiological, clinical and allergological observations on pompholyx. Contact Dermatitis 26:17–21PubMedCrossRefPubMedCentralGoogle Scholar
  51. Löfgren SM, Warshaw EM (2006) Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis 17:165–181PubMedCrossRefPubMedCentralGoogle Scholar
  52. Magina S, Barros MA, Ferreira JA, Mesquita-Guimaraes J (2003) Atopy, nickel sensitivity, occupation, and clinical patterns in different types of hand dermatitis. Am J Contact Dermat 14:63–68PubMedCrossRefPubMedCentralGoogle Scholar
  53. Man I, Ibbotson SH, Ferguson J (2004) Photoinduced pompholyx: a report of 5 cases. J Am Acad Dermatol 50:55–60PubMedCrossRefPubMedCentralGoogle Scholar
  54. Meding B, Alderling M, Albin M, Brisman J, Wrangsjö K (2009) Does tobacco smoking influence the occurrence of hand eczema? Br J Dermatol 160:514–518PubMedCrossRefPubMedCentralGoogle Scholar
  55. Meding B, Swanbeck G (1989) Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol 69:227–233PubMedPubMedCentralGoogle Scholar
  56. Meneghini CL, Angelini G (1979) Contact and microbial allergy in pompholyx. Contact Dermatitis 5:46–50PubMedCrossRefPubMedCentralGoogle Scholar
  57. Menné T, Hjorth N (1983) Pompholyx-dyshidrotic eczema. Semin Dermatol 2:75–80Google Scholar
  58. Miller RM, Coger RW (1979) Skin conductance conditioning with dyshidrotic eczema patients. Br J Dermatol 101:435–440PubMedCrossRefPubMedCentralGoogle Scholar
  59. Montnemery P, Nihlen U, Lofdahl CG, Nyberg P, Svensson A (2005) Prevalence of hand eczema in an adult Swedish population and the relationship to risk occupation and smoking. Acta Derm Venereol 85:429–432PubMedCrossRefPubMedCentralGoogle Scholar
  60. Nielsen NH, Menné T, Kristiansen J, Christensen JM, Borg L, Poulsen LK (1999) Effects of repeated skin exposure to low nickel concentrations: a model for allergic contact dermatitis to nickel on the hands. Br J Dermatol 141:676–682PubMedCrossRefPubMedCentralGoogle Scholar
  61. Niinimaki A (1995) Double-blind placebo-controlled peroral challenges in patients with delayed-type allergy to balsam of Peru. Contact Dermatitis 33:78–83PubMedCrossRefPubMedCentralGoogle Scholar
  62. Odia S, Vocks E, Rakoski J, Ring J (1996) Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current. Acta Derm Venereol 76:472–474PubMedPubMedCentralGoogle Scholar
  63. Ogden S, Clayton TH, Goodfield MJ (2006) Recalcitrant hand pompholyx: variable response to etanercept. Clin Exp Dermatol 31:145–146PubMedCrossRefPubMedCentralGoogle Scholar
  64. Pearce VJ, Mortimer PS (2009) Hand dermatitis and lymphoedema. Br J Dermatol 161:177–180PubMedCrossRefPubMedCentralGoogle Scholar
  65. Petering H, Breuer C, Herbst R, Kapp A, Werfel T (2004) Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 50:68–72PubMedCrossRefPubMedCentralGoogle Scholar
  66. Petersen CS, Menné T (1992) Cyclosporin a responsive chronic severe vesicular hand eczema. Acta Derm Venereol 72:436–437PubMedPubMedCentralGoogle Scholar
  67. Pickenacker A, Luger TA, Schwarz T (1998) Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol 134:378–379PubMedCrossRefPubMedCentralGoogle Scholar
  68. Pitché P, Boukari M, Tchangai-Walla K (2006) Factors associated with palmoplantar or plantar pompholyx: a case-control study. Ann Dermatol Venereol 133(2):139–143PubMedCrossRefPubMedCentralGoogle Scholar
  69. Polderman MC, Govaert JC, le CS, Pavel S (2003) A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol 28:584–587PubMedCrossRefPubMedCentralGoogle Scholar
  70. Rosen K, Mobacken H, Swanbeck G (1987) Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Derm Venereol 67:48–54PubMedPubMedCentralGoogle Scholar
  71. Ruzicka T, Larsen FG, Galewicz D, Horvath A, Coenraads PJ, Thestrup-Pedersen K, Ortonne JP, Zouboulis CC, Harsch M, Brown TC, Zultak M (2004) Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 140:1453–1459PubMedCrossRefGoogle Scholar
  72. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, Kaszuba A, Bissonnette R, Varjonen E, Hollo P, Cambazard F, Lahfa M, Elsner P, Nyberg F, Svensson A, Brown TC, Harsch M, Maares J (2008) Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 158:808–817PubMedCrossRefGoogle Scholar
  73. Scerri L (1999) Azathioprine in dermatological practice. An overview with special emphasis on its use in non-bullous inflammatory dermatoses. Adv Exp Med Biol 455:343–348PubMedCrossRefPubMedCentralGoogle Scholar
  74. Schempp CM, Muller H, Czech W, Schopf E, Simon JC (1997) Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 36:733–737PubMedCrossRefPubMedCentralGoogle Scholar
  75. Schiener R, Gottlober P, Muller B, Williams S, Pillekamp H, Peter RU, Kerscher M (2005) PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study. Photodermatol Photoimmunol Photomed 21:62–67PubMedCrossRefPubMedCentralGoogle Scholar
  76. Schnopp C, Remling R, Mohrenschlager M, Weigl L, Ring J, Abeck D (2002) Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 46:73–77PubMedCrossRefPubMedCentralGoogle Scholar
  77. Schurmeyer-Horst F, Luger TA, Bohm M (2007) Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema. Dermatology 214:99–100PubMedCrossRefPubMedCentralGoogle Scholar
  78. Semhoun-Ducloux S, Ducloux D, Miguet JP (2000) Mycophenolate mofetil-induced dyshidrotic eczema. Ann Intern Med 132:417PubMedCrossRefPubMedCentralGoogle Scholar
  79. Sezer E, Etikan I (2007) Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema. Photodermatol Photoimmunol Photomed 23:10–14PubMedCrossRefPubMedCentralGoogle Scholar
  80. Staerkjaer L, Menné T (1990) Nickel allergy and orthodontic treatment. Eur J Orthod 12:284–289PubMedCrossRefPubMedCentralGoogle Scholar
  81. Stambaugh MD, DeNittis AS, Wallner PE, Heymann WR (2000) Complete remission of refractory dyshidrotic eczema with the use of radiation therapy. Cutis 65:211–214PubMedPubMedCentralGoogle Scholar
  82. Stojanovic D, Nikic D, Lazarevic K (2004) The level of nickel in smoker’s blood and urine. Cent Eur J Public Health 12:187–189PubMedPubMedCentralGoogle Scholar
  83. Stuckert J, Nedorost S (2008) Low-cobalt diet for dyshidrotic eczema patients. Contact Dermatitis 59:361–365PubMedCrossRefPubMedCentralGoogle Scholar
  84. Swartling C, Naver H, Lindberg M, Anveden I (2002) Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J Am Acad Dermatol 47:667–671PubMedCrossRefPubMedCentralGoogle Scholar
  85. Thelin I, Agrup G (1985) Pompholyx–a one year series. Acta Derm Venereol 65:214–217PubMedPubMedCentralGoogle Scholar
  86. Thyssen JP, Maibach HI (2008) Drug-elicited systemic allergic (contact) dermatitis–update and possible pathomechanisms. Contact Dermatitis 59:195–202PubMedCrossRefPubMedCentralGoogle Scholar
  87. Veien N, Menné T (2000) Acute and recurrent vesicular hand dermatitis (pompholyx). In: Menné T, Maibach H (eds) Hand eczema. CRC Press, Boca Raton, pp 147–164Google Scholar
  88. Veien NK (2009) Acute and recurrent vesicular hand dermatitis. Dermatol Clin 27:337–353. viiPubMedCrossRefPubMedCentralGoogle Scholar
  89. Veien NK, Hattel T, Justesen O, Nørholm A (1983) Oral challenge with metal salts. (I). Vesicular patch-test-negative hand eczema. Contact Dermatitis 9:402–406PubMedCrossRefPubMedCentralGoogle Scholar
  90. Veien NK, Hattel T, Justesen O, Nørholm A (1987) Oral challenge with nickel and cobalt in patients with positive patch tests to nickel and/or cobalt. Acta Derm Venereol 67:321–325PubMedPubMedCentralGoogle Scholar
  91. Veien NK, Hattel T, Laurberg G (1994) Chromate-allergic patients challenged orally with potassium dichromate. Contact Dermatitis 31:137–139PubMedCrossRefPubMedCentralGoogle Scholar
  92. Veien NK, Hattel T, Laurberg G (1995) Placebo-controlled oral challenge with cobalt in patients with positive patch tests to cobalt. Contact Dermatitis 33:54–55PubMedCrossRefPubMedCentralGoogle Scholar
  93. Veien NK, Hattel T, Laurberg G (1996) Can oral challenge with balsam of Peru predict possible benefit from a low-balsam diet? Am J Contact Dermat 7:84–87PubMedPubMedCentralGoogle Scholar
  94. Veien NK, Hattel T, Laurberg G (2008) Hand eczema: causes, course, and prognosis I. Contact Dermatitis 58:330–334PubMedCrossRefGoogle Scholar
  95. Veien NK, Kaaber K (1979) Nickel, cobalt and chromium sensitivity in patients with pompholyx (dyshidrotic eczema). Contact Dermatitis 5:371–374PubMedCrossRefPubMedCentralGoogle Scholar
  96. Veien NK, Ølholm LP, Thestrup-Pedersen K, Schou G (1999) Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 140:882–886PubMedCrossRefGoogle Scholar
  97. Vocks E, Plotz SG, Ring J (1999) The dyshidrotic eczema area and severity index – a score developed for the assessment of dyshidrotic eczema. Dermatology 198:265–269PubMedCrossRefPubMedCentralGoogle Scholar
  98. Volden G (1992) Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol 72:69–71PubMedPubMedCentralGoogle Scholar
  99. Wollina U (2008) Pompholyx: what’s new? Expert Opin Investig Drugs 17:897–904PubMedCrossRefPubMedCentralGoogle Scholar
  100. Wollina U, Karamfilov T (2002) Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left–right comparison. J Eur Acad Dermatol Venereol 16:40–42PubMedCrossRefPubMedCentralGoogle Scholar
  101. Yokozeki H, Katayama I, Nishioka K, Kinoshita M, Nishiyama S (1992) The role of metal allergy and local hyperhidrosis in the pathogenesis of pompholyx. J Dermatol 19:964–967PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Dermatology and AllergyHerlev-Gentofte University HospitalHellerupDenmark

Personalised recommendations